Weight Management

Cagrilintide + Semaglutide Combo

Pre-combined formulation of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Dual-pathway appetite suppression targeting both amylin and incretin systems for synergistic metabolic research.

Research specifications

Purity

≥98%

Unit

5mg (2.5mg+2.5mg)

Sequence

COMBINATION

Length

11 amino acids

Molecular weight

Not listed

Availability

In stock